中国医药指南
中國醫藥指南
중국의약지남
Guide of China Medicine
2015年
26期
2-3
,共2页
ER%PR%PS2%子宫内膜癌%非典型增生%正常增生期宫内膜
ER%PR%PS2%子宮內膜癌%非典型增生%正常增生期宮內膜
ER%PR%PS2%자궁내막암%비전형증생%정상증생기궁내막
ER%PR%PS2 protein%Endometrial carcinoma%Atypical hyperplasia
目的:对ER、PR、PS2在子宫内膜癌中表达及临床意义进行分析。方法从我院病理科2008年10月至2012年10月存档蜡块中抽取子宫内膜癌患者100例,为A组;子宫内膜非典型增生患者100例,为B组;正常增生期子宫内膜者100例,为C组,对三组均采用免疫组化方法检测,对比检测水平。结果 C组中ER、PR的表达均显著高于A、B组,其中B组高于A组,差异性明显,具有统计学意义(P<0.05)。PS2在C组中无表达,在A、B组中均有表达,其中A组高于B组,差异明显,具有统计学意义(P<0.05)。A组中高分化患者ER、PR、PS2表达显著高于中分化、低分化患者,差异性明显,具有统计学意义(P<0.05)。腺癌中ER、PR、PS2表达显著高于其他类型癌变患者,差异性明显,具有统计学意义(P<0.05)。结论 ER、PR、PS2的表达同子宫内膜病变情况呈正相关,与子宫内膜癌的发病机制有关,并与其预后有关。子宫内膜癌中ER、PR、PS2表达较高者对内分泌治疗反应及预后较好,故ER、PR、PS2能指导子宫内膜癌术后的内分泌激素治疗,并评估其治疗效果。
目的:對ER、PR、PS2在子宮內膜癌中錶達及臨床意義進行分析。方法從我院病理科2008年10月至2012年10月存檔蠟塊中抽取子宮內膜癌患者100例,為A組;子宮內膜非典型增生患者100例,為B組;正常增生期子宮內膜者100例,為C組,對三組均採用免疫組化方法檢測,對比檢測水平。結果 C組中ER、PR的錶達均顯著高于A、B組,其中B組高于A組,差異性明顯,具有統計學意義(P<0.05)。PS2在C組中無錶達,在A、B組中均有錶達,其中A組高于B組,差異明顯,具有統計學意義(P<0.05)。A組中高分化患者ER、PR、PS2錶達顯著高于中分化、低分化患者,差異性明顯,具有統計學意義(P<0.05)。腺癌中ER、PR、PS2錶達顯著高于其他類型癌變患者,差異性明顯,具有統計學意義(P<0.05)。結論 ER、PR、PS2的錶達同子宮內膜病變情況呈正相關,與子宮內膜癌的髮病機製有關,併與其預後有關。子宮內膜癌中ER、PR、PS2錶達較高者對內分泌治療反應及預後較好,故ER、PR、PS2能指導子宮內膜癌術後的內分泌激素治療,併評估其治療效果。
목적:대ER、PR、PS2재자궁내막암중표체급림상의의진행분석。방법종아원병이과2008년10월지2012년10월존당사괴중추취자궁내막암환자100례,위A조;자궁내막비전형증생환자100례,위B조;정상증생기자궁내막자100례,위C조,대삼조균채용면역조화방법검측,대비검측수평。결과 C조중ER、PR적표체균현저고우A、B조,기중B조고우A조,차이성명현,구유통계학의의(P<0.05)。PS2재C조중무표체,재A、B조중균유표체,기중A조고우B조,차이명현,구유통계학의의(P<0.05)。A조중고분화환자ER、PR、PS2표체현저고우중분화、저분화환자,차이성명현,구유통계학의의(P<0.05)。선암중ER、PR、PS2표체현저고우기타류형암변환자,차이성명현,구유통계학의의(P<0.05)。결론 ER、PR、PS2적표체동자궁내막병변정황정정상관,여자궁내막암적발병궤제유관,병여기예후유관。자궁내막암중ER、PR、PS2표체교고자대내분비치료반응급예후교호,고ER、PR、PS2능지도자궁내막암술후적내분비격소치료,병평고기치료효과。
Objective To analyze the expression and clinical signification of ER,PR and PS2 protein in endometrial carcinoma.Method 300 cases of patients from October 2008 to October 2012 were extracted from the pathology department of our hospital,divided into 3 groups: 100 cases of patients with endometrial carcinoma (group A),100 cases of patients with endometrial atypical hyperplasia (group B) and 100 cases of patients with normal proliferative phase endometrium (group C). Levels of ER,PR and Ki-67 in each group were detected immunohistochemically.Results The expressions of ER,PR were sequentially higher in group A,B and C(P<0.05). There was no expression of PS2 protein in group C. The expression of PS2 protein in group A was higher than that of group B(P<0.05). In group A,the expression of ER,PR and PS2 protein in the cases with well-differentiated endometrial cancer were higher than that in the cases with middle or low differentiation endometrial cancer(P<0.05). The expression of ER,PR and PS2 protein in cases with adenocarcinoma were significantly higher than that of cases with other types of carcinoma(P<0.05).Conclusion The expression of ER,PR and PS2 protein were positively correlated with endometrial lesions,associated with the pathogenesis and prognosis of endometrial carcinoma. Those cases with higher expression of ER,PR and PS2 protein in endometrial carcinoma had a better response to endocrine therapy,resulting in guidance and evaluation of endocrine therapy after operation according to the expression of ER,PR and PS2 protein.